Michael S. Hearne is CEO & COO +1 at Odonate Therapeutics, Inc. (ODT). They have made 3 open-market trades across 2 companies since 2018, most recently 2026-05-18.
CIK 0001759910
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
3 open-market purchases totalling $5.2M since 2018, never a sale. Too few scored purchases to measure a record yet.
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.